Mdivi-1 |
|
|
|
|
|
inhibitor |
Positive |
|
296 |
Mdivi-1 |
|
|
|
|
|
|
Positive |
|
248 |
Urolithin A |
|
|
|
|
|
enhance |
Positive |
|
248 |
Ozone |
1 μg O 3/mL |
|
|
HeLa cells |
|
|
Positive |
|
247 |
Ozone |
10 μg O 3/mL |
|
|
HeLa cells |
|
|
Positive |
|
247 |
Nicotine |
10 mM |
|
Human |
Human embryonal carcinoma cells (NT2/D1) |
|
|
Positive |
|
247 |
Cisplatin |
3 mg/kg bodyweight |
twice a week for 2 weeks |
Mouse |
Mouse tibial nerves and dorsal root ganglia (L1–L4) |
|
|
Positive |
|
247 |
Doxorubicin |
7.2 μM DXR for 24 hrs |
|
Human |
fibroblasts |
|
|
Positive |
|
247 |
MDMA |
20 μM MDMA mixture for 24 hrs |
|
|
Mouse primary hippocampal neurons |
|
|
Positive |
|
247 |
Metamfetamine |
0.5, 1, 2 mM Meth for 24 hrs |
|
|
Human neuroblastoma SH- SY5Y |
|
|
Positive |
|
247 |
Perfluorooctanoic acid |
In utero exposure (GD 1–17) to 1 mg/kg bodyweight dam |
|
|
Post-natal day 91 mouse livers |
|
|
Positive |
|
247 |
Cadmium |
In vitro: 12uM CdCl2 In vivo: 2mg/kg CdCl2 |
|
|
Rat hepatocytes |
|
|
Positive |
|
247 |
Manganese |
Infusion of 1 μM MnCl2 |
|
|
Rat glia |
|
|
Positive |
|
247 |
Methylmercury |
20 μM |
|
|
Human HepG2 cells |
|
|
Positive |
|
247 |
Chlorpyrifos |
30 μM |
|
|
Human stem cell-derived neural progenitor cells |
|
|
Positive |
|
247 |
2,4-dinitrophenol |
50 μM DNP at 3 hours post fertilization (hpf) |
|
|
Danio rerio |
|
|
Positive |
|
247 |
CCCP |
20 μM CCCP for 1 to 3 hours |
|
|
HeLa cells |
|
|
Positive |
|
247 |
FCCP |
10 μM FCCP for 48 to 72 hours |
|
|
HeLa cells |
|
|
Positive |
|
247 |
Ultraviolet B |
100 mJ/cm2 |
|
human |
Normal epidermal keratinocytes |
|
|
Positive |
|
247 |
Ultraviolet C |
60 mJ/cm2 |
|
Mouse |
embryonic fibroblasts |
|
|
Positive |
|
247 |
XCT790 |
|
|
|
|
|
inhibit |
Positive |
|
308 |
Rosiglitazone |
|
1, 2, 4, 7, 24, and 48 hrs |
Murine |
differentiated 3T3-L1 and C3H/10T1/2 adipocytes |
|
increase |
Positive |
|
179 |
Wortmannin |
100 nM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
hydroxychloroquine |
30 μM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
3-methyladenine |
10 mM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
Bafilomycin A1 |
50 nM |
|
|
SH-SY5Y neuroblastoma cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
CCCP |
10 μM or 25 μM |
|
|
mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
|
Positive |
|
252 |
earle’s balanced salt solution |
|
|
|
|
|
|
Positive |
|
252 |
rapamycin |
|
|
mouse |
embryonic retinas |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye |
|
Positive |
|
252 |
Cyclosporin A |
5 μM |
|
|
mouse embryonic fibroblasts (MEFs) and SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye |
block |
Positive |
|
252 |
Nicotinamide |
5 mM |
6h |
|
SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
induce |
Positive |
|
252 |
fisetin |
10 μM |
6h |
|
SH-SY5Y cells |
Mitochondrial population levels were determined by flow cytometry using MitoTracker Deep Red (MTDR) dye. |
induce |
Positive |
|
252 |
Xanthohumol |
30μM |
24hr |
|
MCF7 cells |
using the MAP1LC3II/I ratio to monitor the autophagic flux; quantifiedPMPCB staining |
block |
Positive |
|
283 |
sertraline |
|
|
|
|
|
decrease |
Positive |
|
307 |
Fluoxetine |
|
|
|
|
|
decrease |
Positive |
|
307 |
quercetin |
|
|
|
HepG |
|
|
Positive |
|
263 |
quercetin |
|
|
|
brain |
|
|
Positive |
|
265 |
colchicine |
|
|
|
|
|
|
Positive |
|
185 |
Teriflunomide |
|
|
|
|
|
induce |
Positive |
|
295 |
Leflunomide |
50 μM |
48 hr |
|
HeLa cells, C2C12 muscle cells, MEF cells |
Mfn2 and Mfn1 mRNA levels; MFN2, MFN1, and porin protein levels; images of mitochondrial morphology ; |
induce |
Positive |
|
295 |
Chlorpyrifos |
30 μM |
|
Human |
Human induced pluripotent stem cells (iPSCs) |
|
increase |
Positive |
|
242 |
docetaxel |
|
|
|
|
|
|
Positive |
|
185 |
BGP-15 |
50 μM |
4hr |
|
WRL-68 cells |
Polyethylene glycol (PEG) fusion assay; OPA1 GTPase assay and OPA1-OPA1 interactions |
induce |
Positive |
|
297 |
piceatannol |
|
48hr |
|
Mfn1−/− MEFs stably expressing an Mfn1 promoter reporter construct |
Relative luciferase activity was determined in Mfn1−/− MEFs carrying the Mfn1 promoter reporter |
|
Positive |
|
276 |